Results 71 to 80 of about 298,715 (300)

The supplier’s evaluation of material requirements urgency.

open access: yes, 2023
The supplier’s evaluation of material requirements urgency.
Zhichao Ma (2458558)   +2 more
core   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Inclisiran in a real-world single-center registry of patients with very high atherosclerotic cardiovascular risk

open access: yesAtherosclerosis Plus
Background: A mean relative 50 % reduction of LDL cholesterol (LDLc) levels was observed in randomized studies in patients treated with inclisiran, a small-interfering-RNA therapeutic agent that reduces hepatic synthesis of PCSK9.
Antonio Centola   +9 more
doaj   +1 more source

Mediated Urgency: Exploring GBTQ+ Perceptions of Antibiotic-Resistant Sexually Transmitted Infections

open access: yes
Often, research takes place once a health issue is already at ‘crisis’ point. However, health professionals and populations can have different understandings of ‘urgency’.
Applegate, T.   +21 more
core   +1 more source

Contingency table for the overall urgency levels.

open access: yes, 2022
Contingency table for the overall urgency levels.
Kilson Moon (10642870)   +7 more
core   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

open access: yesMolecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau   +9 more
wiley   +1 more source

Attitudes of cancer patients toward ctDNA‐based liquid biopsy for follow‐up

open access: yesMolecular Oncology, EarlyView.
This mixed‐methods study explored cancer patients' experiences, knowledge, and preferences regarding ctDNA‐based liquid biopsy for follow‐up. Awareness of ctDNA was low and recall of previous liquid biopsy was imperfect, yet acceptance was high.
Siddharth Chhajlani   +7 more
wiley   +1 more source

Integrating Preclinical and Clinical Models of Negative Urgency [PDF]

open access: yes, 2019
Overwhelming evidence suggests that negative urgency is robustly associated with rash, ill-advised behavior, and this trait may hamper attempts to treat patients with substance use disorder.
Meredith Halcomb   +5 more
core   +1 more source

Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas

open access: yesMolecular Oncology, EarlyView.
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis   +20 more
wiley   +1 more source

Suggested solutions for different levels of urgency.

open access: yes, 2023
Suggested solutions for different levels of urgency.
Peng Dong (662981)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy